Skip to main content
Premium Trial:

Request an Annual Quote

Cyrus Harmon

Premium

Cyrus Harmon, vice president of computational genomics at Affymetrix, is taking a three-year leave to complete a PhD in genetics at the University of California, Berkeley. Harmon dropped out of grad school five years ago to launch Neomorphic, the bioinformatics company that Affymetrix acquired last year.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.